Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.44.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.44.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
FL.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.45.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.45.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.45.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.45.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FP.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FP.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.102ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.102ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.102ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.102NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FK.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used